Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →
logo
Get CLEATUS

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institutes of Health is soliciting applications for Research Units as part of the Pancreatic Cancer Detection Consortium to advance the early detection of pancreatic ductal adenocarcinoma and the characterization of precursor lesions. These multi-disciplinary teams will focus on developing and testing molecular and imaging biomarkers to identify high-risk patients and those with lesions likely to progress to cancer. Key activities include utilizing machine learning for biomarker discovery, conducting validation studies, and collecting longitudinal biospecimens for a centralized biorepository. The program emphasizes a collaborative framework where Research Units share data and specimens, supported by a Management and Data Coordination Unit responsible for study design, statistical analysis, and data stewardship. This initiative aligns with the NCI's scientific framework to improve screening for populations with genetic predispositions or family histories of the disease, aiming to facilitate early intervention and improved patient outcomes.

General Info

NCI seeks Research Units to develop biomarkers and imaging for early pancreatic cancer detection.

Agency

Department Of Health And Human Services → National Institutes Of Health

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
Contacts1 person available
OfficeUSA
Organization / AgencyDepartment Of Health And Human Services → National Institutes Of Health
Office AddressUSA
Contacts
DCP CBB
contact@example.gov

Full Description

Show more

Through this Notice of Funding Opportunity (NOFO), NCI solicits applications for the Research Units (RUs), one of the two scientific components of the Pancreatic Cancer Detection Consortium (PCDC), to conduct research on early detection of pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions to identify patients who are at high risk of progression to cancer. The PCDC will continue to address one of the four research priorities identified in the NCI's 2014 Scientific Framework for Pancreatic Ductal Adenocarcinoma (PDAC). The PCDC will support research for the development and testing of new molecular and imaging biomarkers for detecting PDAC early and for identifying patients at high risk of PDAC (because of genetic factors, family history and/or the presence of precursor lesions) who could be candidates for early intervention. 

The PCDC-RUs will consist of multi-disciplinary teams and will undertake studies to: identify and test biomarkers measurable in bodily fluids for early detection of PDAC and/or its precursor lesions; develop molecular- and/or imaging-based markers of pancreatic cysts and determine which lesions are likely to progress to cancer; develop molecular- and/or imaging-based approaches for screening populations at high risk of PDAC; use machine learning and computational approaches towards biomarker discovery and/or validation; and conduct biomarker validation studies. The PCDC-RUs will also collect longitudinal biospecimens for building a biorepository. Each PCDC-RU is expected to participate in collaborative activities with other PCDC-RUs and share ideas, biospecimens, and data within the Consortium.

The other scientific component of the PCDC will be the Management and Data Coordination Unit, which will provide support toward study design, protocol development, statistical analysis, coordination, harmonization, data management and stewardship for the trans-PCDC collaborative projects, including biorepository building effort. 

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
QuickSink Notice of Contract Action ( NOCA)
Solicitation # QSK1
FA8681 Aflcmc Ebd

POSTED

about 17 hours ago

DEADLINE

in 15 days
View Details
NAICS: 541715
New
Federal
Measurement of Core Temperature and Thermoregulatory Responses during and after Spaceflight in Astronauts
Solicitation # 80JSC027CTTR
NASA Johnson Space Center is issuing a sources sought Request for Information under solicitation number 80JSC027CTTR to gather data on the measurement of core body temperature and thermoregulatory responses in astronauts. The NASA Human Research Program seeks validated approaches and technology recommendations to monitor these responses before, during, and after spaceflight, specifically during normal daily activities, exercise, and re-entry or landing. The scope includes identifying tools currently available for low-Earth orbit as well as those in development for future Moon and Mars missions, utilizing retrospective methodologies for existing datasets, and proposing studies involving short- and long-duration missions or analogs such as parabolic flight. This RFI is for planning purposes only and does not constitute a formal solicitation or a commitment by the government. While no formal period of performance is established, the work is targeted for completion of the International Space Station in 2032, with potential extensions to commercial destinations and Artemis missions. Interested parties must submit their electronic responses to Tracy L. Quintanilla and Katelyn R. Jaime by October 14, 2026, at 2:00 p.m. CT. All submissions must reference the specific RFI title and number. The project falls under NAICS code 541715 and adheres to Human Spaceflight and Aviation Standards.
NASA Johnson Space Center

POSTED

about 17 hours ago

DEADLINE

in 14 days
View Details
NAICS: 541715
New
Federal
AI-Enabled Incident Response System with sUAS and Human Copilots (AIRS-COP)
Solicitation # 693JJ3-26-SN-0010
693JJ3 Acquisition And Grants Mgt

POSTED

about 17 hours ago

DEADLINE

in 15 days
View Details
NAICS: 541715
New
Federal
16th Air Force Commercial Solutions Opening
Solicitation # FA7037-23-S-C0001
The 16th Air Force is utilizing a Commercial Solutions Opening (CSO) under 10 USC 3458 and DFARS 212.70 to acquire innovative commercial items, technologies, and services to close capability gaps and advance USAF mission capabilities. This umbrella solicitation, FA7037-23-S-C0001, allows for the issuance of various specific Calls to address diverse technical needs, including Electromagnetic Warfare, Information Operations, Electromagnetic Digital Communications, and Multi-Domain Innovation. All items and services under this CSO are treated as commercial items, and awards may be issued as traditional contracts—such as Firm Fixed Price, Fixed Price Incentive, or IDIQ—or as Other Transaction Agreements (OTAs). The procurement process typically follows a two-step submission cycle. In Step I, interested offerors submit a one-page Quad Chart and a white paper, generally limited to two pages, detailing their technical approach, goals, and milestones. If invited by the Contracting Officer, offerors proceed to Step II to submit a full technical proposal and a proposed Statement of Work. Evaluation is conducted via peer or scientific review, focusing on technical merit and applicability. Key requirements for offerors include active SAM.gov registration with a Unique Entity Identifier (UEI) and adherence to specific Cybersecurity Maturity Model Certification (CMMC) levels. Previous and current Calls have targeted a wide range of specialized requirements, such as Computational Fluid Dynamics (CFD) modeling for data centers, AI-enabled Security Operations Centers (AI-ESOC), and the modernization of the Air Force Information Network (AFIN) premise wiring. Some requirements mandate local computational solving on government equipment to ensure data sovereignty. While the overarching solicitation remains open for annual updates, funding is allocated on a per-call basis, and the government maintains no obligation to award contracts until specific funding is available and negotiations are successful.
FA7037 Amic Det 2 Jbsa

POSTED

about 17 hours ago

DEADLINE

in 12 months
View Details
NAICS: 541715
New
Federal
Modernization of Scientific and Technical Intelligence (SandTI;) Prototype Effort
Solicitation # 2026SANDTIPROTOTYPE
The National Air and Space Intelligence Center (NASIC) and the National Space Intelligence Center (NSIC) are conducting market research to identify industry capabilities for prototyping and operationalizing a scalable, modern, model-based, and data-centric Scientific and Technical Intelligence (S&TI) environment. This initiative, explored under 10 U.S.C. 4022 Prototype Other Transaction Authority, focuses on modernizing mission-critical applications, databases, and analytic pipelines. Key technical domains include signals intelligence, electronic attack intercept and engineering models, jammer simulation engines, and the integration of AI/ML and MBSE/SysML standards. The effort specifically targets the modernization of tools such as Analyst Notepad, ASPIRE, and Data Characterizer, with the goal of deploying containerized solutions into classified cloud enclaves like JWICS AWS C2S GovCloud. This is a sources-sought notice under NAICS 541715 and does not constitute a formal solicitation or commitment to award. Interested parties must submit a five-page capability statement by October 9, 2026, detailing their corporate profile, technical experience in threat modeling and classified software delivery, and their ability to provide TS/SCI-cleared personnel and facilities. Performance is expected to occur at Wright-Patterson AFB, Ohio, and within contractor SCIF facilities. Respondents are required to provide rough order of magnitude cost estimates for an initial 12-month prototype demonstration and a subsequent evolution period ranging from 13 to 48 months.
FA8604 Aflcmc Pzi

POSTED

about 17 hours ago

DEADLINE

in 9 days
View Details
NAICS: 541715
New
Federal
NRL Long Range Broad Agency Announcement (BAA) for Basic and Applied Research
Solicitation # N00173-24-S-BA01
The Naval Research Laboratory (NRL) has issued a Long Range Broad Agency Announcement (BAA), solicitation number N00173-24-S-BA01, to fund basic and applied scientific research supporting Navy and Marine Corps operational requirements. This competitive solicitation targets innovative proposals across four primary directorates: Systems (Code 5000), Materials Science and Component Technology (Code 6000), Ocean and Atmospheric Science and Technology (Code 7000), and the Naval Center for Space Technology (Code 8000). Key research areas include high frequency radar, computational electromagnetics, plasma science, ocean dynamics, and spacecraft technology. Recent amendments have extended the white paper acceptance deadlines and added specific topics, such as the AFFF Alternative Program for fluorine-free foam compatibility. The acquisition process follows a two-step approach where prospective offerors first submit a five-page white paper and a rough cost estimate to the relevant Technical Point of Contact. If the research is deemed promising, the government will invite the offeror to submit a formal proposal. Awards may take the form of contracts, grants, cooperative agreements, or other transactions, with contract types including Firm Fixed Price and Cost Plus Fixed Fee. Evaluation is based on a trade-off methodology prioritizing technical merit, naval relevance, and offeror capability. Strict administrative and security requirements apply, including the necessity for a current Secret or Top Secret facility clearance for classified work and compliance with U.S. export control laws. Offerors must also disclose any organizational conflicts of interest and provide specific representations and certifications. The BAA encourages submissions from educational institutions, small businesses, and minority-serving institutions. All electronic submissions must adhere to strict formatting and file size limits, with a final response deadline of September 30, 2026.
Naval Research Laboratory

POSTED

about 17 hours ago

DEADLINE

in 3 months
View Details
NAICS: 541715
New
Federal
RFI for Next Generation Hypersonic Cruise Missiles
Solicitation # DARPA-SN-26-93
The Defense Advanced Research Projects Agency (DARPA) Tactical Technology Office has issued Request for Information (RFI) DARPA-SN-26-93 to gather industry input for the development of a Next Generation Hypersonic Cruise Missile (NGHCM). This RFI is intended to refine technical requirements, validate programmatic assumptions, and inform the acquisition strategy for a future competitive program solicitation. The agency is specifically seeking revolutionary concepts and technologies that offer significant advancements in range, speed, and altitude while maintaining a focus on affordability and manufacturability. The RFI targets three primary focus areas: Trade Space Exploration and Concept Development, Critical Technology Evaluation, and Innovative Test and Evaluation Technologies. DARPA aims to encourage innovative teaming arrangements between traditional defense contractors, non-traditional contractors, technology developers, and specialized test and evaluation providers. Interested parties must submit responses in English, not exceeding fifteen single-sided pages, using 11-point font and one-inch margins. Submissions should include a technical description addressing one or more focus areas, an optional graphic overview slide, and a bibliography. Strict protocols are in place for the handling of sensitive information; all documents must be clearly labeled with the special notice number, respondent organization, and response title. Proprietary information must be explicitly marked, and Controlled Unclassified Information (CUI) must comply with DoDI 5200.48 and NIST SP 800-171 standards. Classified submissions must be handled separately from unclassified portions and require pre-coordination via email. The deadline for responses is November 6, 2026. As this is an RFI for planning purposes, it does not constitute a formal solicitation, and DARPA will not provide reimbursement for costs incurred in responding.
Defense Advanced Research Projects Agcy

POSTED

about 17 hours ago

DEADLINE

in about 1 month
View Details
NAICS: 541715
New
Federal
NASA SBIR/STTR FY 2026-2027 Broad Agency Announcement (BAA)
Solicitation # 80NSSC26R0003
The NASA SBIR/STTR FY 2026-2027 Broad Agency Announcement (BAA), solicitation 80NSSC26R0003, serves as an omnibus framework to procure research and development activities from small businesses. This BAA is not a standalone solicitation but establishes the overarching objectives, eligibility criteria, and proposal instructions for Phase I and Phase II projects. Specific funding opportunities and research subtopics will be released through separate appendices throughout the effective period, which ends on September 30, 2027. The program is a total small business set-aside under NAICS code 541715, administered by the NASA Shared Services Center. Phase I projects focus on demonstrating technical feasibility with a maximum contract value of 225,000 dollars and performance periods ranging from 6 to 13 months. Phase II projects aim to commercialize the innovation for federal or commercial markets, with a maximum value of 1,275,000 dollars and a performance period of up to 24 months. Awards are firm fixed price and are based on a multi-stage review process involving administrative pass/fail gates, technical responsiveness, and evaluations of commercial potential and technical merit. Eligible offerors must maintain active SAM registration with a Unique Entity Identifier and CAGE code, and must be registered with the SBA Company Registry. Proposals must be submitted electronically and include contact information, endorsed certifications, a non-proprietary summary, and a budget. NASA will conduct risk-based due diligence reviews regarding cybersecurity and foreign ownership. Additionally, any use of federal facilities requires a signed agreement as a condition for award. Invoicing is handled electronically via the Department of Treasury's Invoice Processing Platform.
NASA Shared Services Center

POSTED

about 17 hours ago

DEADLINE

in 12 months
View Details
NAICS: 541715
New
Federal
DHA Enterprise-Wide Commercial Solutions Opening (CSO)
Solicitation # HT003826SC005
The Defense Health Agency (DHA) has established the Enterprise-Wide Commercial Solutions Opening (CSO), solicitation number HT003826SC005, to identify and acquire commercial products, services, and non-developmental items. Active from August 7, 2026, through August 6, 2027, this initiative seeks commercially available capabilities that can be deployed immediately or modified to meet DHA requirements across its Medical Digital Solutions, Medical Services, and Medical Products portfolios. The government will utilize a variety of award vehicles, including firm-fixed-price FAR-based contracts and Other Transaction (OT) agreements for research, prototyping, and experimental purposes under authorities such as 10 U.S.C. 3458, 3201, 4021, 4022, and 4023. The procurement process is driven by the issuance of specific Areas of Interest (AoI), which define problem statements, objectives, and submission criteria. Submissions undergo a streamlined, multi-phase evaluation process: Phase I involves a pitch or white paper evaluated on a Go/No-Go basis for strategic alignment and feasibility; Phase II may include an optional oral presentation or demonstration to assess technical viability; and Phase III requires a full commercial proposal evaluated on technical merit, cost reasonableness, and past performance. This CSO is administered by the DHACA Defense Healthcare Management Systems Contracting Division and is designed to prioritize cost-effective, commercially viable solutions to enhance healthcare readiness and patient safety.
Defense Health Agency (dha)

POSTED

about 17 hours ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Federal
Space Environment Technologies and Science (SETS) Broad Agency Announcement (BAA) Call 004
Solicitation # FA945326RX012
FA9453 Afrl Rvk

POSTED

about 17 hours ago

DEADLINE

in 29 days
View Details
NAICS: 541715
New
Federal
Space Environment Technologies and Science (SETS) Broad Agency Announcement (BAA)
Solicitation # FA9453-23-R-X001
The Space Environment Technologies and Science (SETS) program is a Broad Agency Announcement issued by the Air Force Research Laboratory to support research into space and environmental impact technologies. The program aims to quantify how the space environment affects Department of Defense and national security systems, focusing on the ability to predict, mitigate, and exploit these effects. Research is divided into five primary technical areas: Solar, Solar Wind, and Ionospheric Effects; Thermosphere, Satellite Drag, and the Reentry Environment; Plasma Physics and Chemistry; Particle Effects and Radiation Belt Environment; and the Cislunar Environment. The program seeks deliverables ranging from scientific reports and software to hardware prototypes, with an estimated funding profile of 98.5 million dollars spanning fiscal years 2024 through 2031. This is a closed BAA that remains active for eight years, meaning proposals and white papers must be submitted in response to specific individual Calls announced via SAM.gov rather than the baseline announcement. Evaluation is based on scientific and technical merit, relevance to mission needs, and the soundness of the technical approach. Applicants must be registered in the System for Award Management and adhere to strict security and citizenship requirements, including U.S. citizenship for personnel accessing government facilities or networks. The procurement process may involve either a standard proposal path or a white paper process, with specific formatting and page limits for technical and cost volumes. Award decisions are based on a categorization process, with a final determination of price fairness and cost realism conducted by the Contracting Officer.
FA9453 Afrl Rvk

POSTED

about 17 hours ago

DEADLINE

in about 2 years
View Details
NAICS: 541715
New
Federal
SOURCES SOUGHT FOR COOPERATIVE RESEARCH & DEVELOPMENT PARTNERSHIPS HYPERSONIC INFRARED TARGET SENSING – TRANSITION OPPORTUNITY (HITS-TO)
Solicitation # W911NF-26-HITS-TO
The Hypersonic Infrared Target Sensing Transition Opportunity (HITS-TO) is a Sources Sought notice issued by the Department of Defense to establish cooperative research and development partnerships with U.S. industry, national laboratories, University Affiliated Research Centers, and Federally Funded Research and Development Centers. The initiative aims to create technology transition pathways to mature infrared seeker innovations from TRL/MRL 3-4 to TRL/MRL 5-6, ultimately integrating them into working prototypes for hypersonic weapons. Key technical objectives include improving target location through hypersonic environments and hot windows, developing gimbal-less target discrimination and tracking, creating high-fidelity multi-physics simulations, and conducting hardware-in-the-loop validation at extreme temperatures. This is a non-funded opportunity where partners are expected to self-finance their participation, with a preference for exceptional U.S. entrepreneurial entities. Interested parties must submit a Technical Capability Summary Statement (TCSS) limited to six pages, along with a cover sheet and optional past performance appendix. Submissions are evaluated based on existing technical expertise, engineering development capacity, and financial ability. Due to the nature of the work, respondents must demonstrate the ability to handle controlled unclassified information or classified data, providing necessary facility and personnel clearance documentation. The submission deadline is October 15, 2026, at 1600 ET.
W6QK Acc-Apg Durham

POSTED

1 day ago

DEADLINE

in 15 days
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

New
Grant
Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)The National Institutes of Health is forecasting a Notice of Funding Opportunity to solicit applications for early to definitive clinical trials. This initiative seeks proposals testing a wide range of interventions, including drugs, devices, biologics, procedures, and behavioral or social interventions, provided they align with the research missions of the participating NIH Institutes, Centers, and Offices. The funding will utilize a bi-phasic, milestone-driven R61/R33 activity code with a maximum project period of seven years. The R61 phase focuses on planning activities, while the R33 phase supports the actual clinical trial. Although applications are not currently being accepted, this notice serves as an advance alert for investigators with expertise in trial design, implementation, and stakeholder engagement to begin developing collaborations and projects.

POSTED

2 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed)The National Institute on Aging intends to issue a single U24 cooperative agreement award to support the continued operation and expansion of the Exceptional Longevity Data Management and Coordinating Center. Serving as the central hub for human longevity translational research, the center integrates deeply phenotyped cohorts and multi-omics datasets to enable cross-cohort analyses and collaborative research. Key responsibilities include data harmonization, the implementation of common data standards, and the management of the ELITE Portal, which provides the research community with secure access to analytical tools and cloud-based computational workspaces. The upcoming funding opportunity will require the Coordinating Center to expand its capabilities in artificial intelligence, machine learning, and the integration of diverse datasets across different species. Future objectives include the development of curated target knowledgebases for therapeutic targets, the enhancement of portal interoperability according to FAIR data principles, and the strengthening of community engagement through specialized training and workshops. This notice serves as a forecast to allow potential applicants to establish collaborations before the official solicitation is released.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

7 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Grant
Immune Drivers of Autoimmune DiseaseThe National Institute of Allergy and Infectious Diseases seeks to support the Immune Drivers of Autoimmune Disease network to investigate the triggers and early mechanisms of autoimmunity in humans. The primary goal is to develop tools for risk prediction and staging, identify pre-clinical immune mechanisms, and utilize artificial intelligence and big data to prevent autoimmune diseases. This initiative emphasizes the creation of preclinical cohorts and the use of remote recruitment and sampling to advance medical research. The network will be managed by a Coordinating Center responsible for data harmonization, sample sharing, and the administration of an Infrastructure Opportunity Fund for collaborative research projects. This forecast, issued by the National Institutes of Health under the Department of Health and Human Services, establishes a framework for shared infrastructure and steering committee oversight to identify common pathways and prevention opportunities.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

7 days ago

DEADLINE

N/A
View Details
NAICS: 513130
Grant
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)The National Institutes of Health, through the Department of Health and Human Services, is soliciting applications for the NLM Grants for Scholarly Works in Biomedicine and Health program. This initiative provides funding for the creation of book-length manuscripts and other integrative scholarly works, such as critical reviews and analytical syntheses, designed to benefit U.S. health professionals, scientists, and public health practitioners. The primary goal is to organize and disseminate biomedical and health-related knowledge to improve research, education, and clinical practice. This opportunity is listed as a forecast with a posted date of September 24, 2026. It specifically prohibits the use of clinical trials. Interested parties can contact the NLM Extramural Programs office for further information regarding the application process and program requirements.
Book Publishers

POSTED

7 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Grant
Partnerships for Advancing Development of Diagnostics for Infectious DiseasesThe National Institute of Allergy and Infectious Diseases, under the National Institutes of Health, is seeking to establish partnerships between academic or small business investigators and industrial partners to advance the translational development of diagnostic tests for infectious diseases. This initiative focuses on moving diagnostics that have already demonstrated proof-of-concept through the commercialization process by aligning researchers with experienced industry partners to de-risk development and ensure products are fit for purpose. The program will be supported by a science advisory board and NIAID oversight, incorporating annual meetings and workshops to facilitate collaboration and knowledge exchange. This effort is authorized under the Public Health Service Act and federal regulations to ensure that promising diagnostic technologies are successfully translated into tools for treating and preventing infectious diseases.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

7 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE)The National Institute of Allergy and Infectious Diseases, under the Department of Health and Human Services, is forecasting the LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE) program. This initiative aims to bridge the gap between traditional clinical trial findings and real-world application by supporting collaborations on effectiveness trials, pragmatic trials, and hybrid effectiveness-implementation studies. The program focuses on the prevention and treatment of HIV, including associated coinfections and comorbidities, across all age groups and various points of care. The goal of the program is to advance cross-cutting research in epidemiology, implementation science, and clinical, behavioral, and social sciences. This effort aligns with the broader NIH mission to implement research advances in HIV/AIDS. The opportunity is authorized under the Public Health Service Act and relevant federal regulations, with administrative oversight provided by the Division of AIDS Epidemiology Branch.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

7 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Collaborative Centers in Children’s Environmental Health Research and Translation (P2C Clinical Trial Optional)The National Institutes of Health, under the Department of Health and Human Services, is seeking applications to establish a national network of Children's Environmental Health Research Translation Centers. These centers are designed to protect and improve children's health by developing scientific questions and public health interventions focused on translational research. A primary objective is to move evidence-informed biomedical findings into practical application for the wider community while mentoring a new generation of investigators in the field. Beyond research and translation, the program will function as a national resource to coordinate responses to emerging environmental exposures that impact children. The initiative emphasizes the creation of actionable strategies to prevent harm and ensure a healthy future for children through collaborative efforts within the environmental health community.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

7 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Grant
The Role of the Innate Immune System in the Pathogenesis of Type 1 DiabetesThe National Institute of Allergy and Infectious Diseases, under the Department of Health and Human Services, is forecasting a grant opportunity to investigate the role of the innate immune system in the initiation of Type 1 Diabetes. Funded by the Special Statutory Funding Program for Type 1 Diabetes Research, this initiative seeks to identify genetic and environmental causes of the disease by examining how innate immune components interact with beta cells and pancreatic tissues. The program emphasizes the use of new approach methodologies to determine the timing and impact of environmental triggers that activate these immune pathways. The primary objective is to improve the early identification of high-risk individuals and develop future prevention and therapeutic strategies. This effort is conducted under the authority of the Public Health Service Act and relevant federal regulations. Interested parties can contact the RISP-T1D point of contact for further information regarding this forecast.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

7 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)The National Institute of Neurological Disorders and Stroke (NINDS) is seeking to support scientific research using data from intermediate-size patient population expanded access protocols for Amyotrophic Lateral Sclerosis (ALS). To be eligible, protocols must provide access to an investigational drug or biological product for individuals with ALS and generate data that supports research into the prevention, diagnosis, mitigation, treatment, or cure of the disease. Research goals may include analyzing the effects of products on biomarkers, target engagement, safety and outcome information such as survival and hospitalization, or general patient experience data. This opportunity is currently listed as a forecast by the National Institutes of Health under the Department of Health and Human Services, and applications are not being solicited at this time. The notice serves as a preliminary announcement to allow potential applicants sufficient time to develop responsive projects. Interested parties can contact the ALS Program for further information.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

8 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Research to Improve Rigor, Replicability, and Reproducibility in Biomedical and Behavioral SciencesThe National Institute of Neurological Disorders and Stroke, in collaboration with other NIH entities, is forecasting support for research projects aimed at enhancing biomedical and behavioral rigor, replicability, and reproducibility. Key areas of interest include assessing the scientific impact of these improvements, creating frameworks for selecting high-value replication studies, and measuring the robustness and generalizability of research findings to drive scientific innovation. This notice serves as a forecast to allow potential applicants to establish collaborations and develop responsive projects, as formal applications are not currently being solicited. Interested parties can contact the NINDS Office of Research Quality for further information.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

9 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs)The National Institutes of Health, through the National Institute of Mental Health, is issuing a forecast for a Notice of Funding Opportunity titled Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs). This initiative aims to establish a research network to evaluate the clinical effectiveness, safety, and durability of rapid-acting treatments such as ketamine, esketamine, and psilocybin for individuals with serious mental illnesses. The primary objective is to generate actionable real-world evidence to determine how these interventions can be safely and sustainably integrated into routine clinical practice across diverse patient populations and healthcare settings. By addressing current gaps in knowledge regarding implementation and long-term benefits, the project seeks to inform future healthcare delivery strategies for emerging psychotropic treatments.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

15 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Emerging Global Leader Award (K43)The Emerging Global Leader Award (K43), issued by the National Institutes of Health under the Department of Health and Human Services, provides salary and research support to junior faculty and research scientists based at academic or research institutions in Low- and Middle-Income Countries. The program focuses on biomedical, behavioral, and clinical research that leverages unique opportunities in these regions to create generalizable knowledge benefiting both U.S. and international populations. Recipients must engage in intensive mentored research and career development guided by senior researchers from both the U.S. and their respective home countries. By leveraging existing NIH research investments, the initiative aims to develop global research leaders who can mentor future investigators and strengthen international research networks.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

15 days ago

DEADLINE

N/A
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS